Unexpected effect of MS drug Unexpected effect of MS drug Karl Carlström and Fredrik Piehl Photo: Stefan Zimmerman Researchers at CMM have studied the mechanism of action of a drug used to treat...
New findings about how Parkinson's disease develops New findings about how Parkinson's disease develops A new study by researchers at CMM shows that the protein alpha-synuclein, which accumulates in patients with Parkinson’s disease, occurs...
New method divides patients with ulcerative colitis in groups New method divides patients with ulcerative colitis in groups Researchers at CMM have found a way of using gene expression conserved across species to divide patients with the inflammatory...
Rheumatoid arthritic pain could be caused by antibodies Rheumatoid arthritic pain could be caused by antibodies In a recently published study, researchers at CMM has shown that antibodies that exist in the joints before the onset of rheumatoid...
Financial support from The Swedish Childhood Cancer Fund to Ann Nordgren for her research position Financial support from The Swedish Childhood Cancer Fund to Ann Nordgren for her research position Research positions are awarded once a year by the Swedish Childhood Cancer Fund. In 2019,...
Speaker: Oren Parnas, Ph.D., The Hebrew University of Jerusalem, Israel
CMM Lecture Hall, Visionsgatan 18, ground floor, L8:00
Host: CMM Researcher Eduardo J. Villablanca, Associate Professor, Karolinska Institutet, Department of Medicine, Immunology and Allergy Unit, Center for Molecular Medicine (CMM)
Speaker: Stefan Knapp, Professor, Goethe University and SGC Frankfurt.
Rolf Luft Auditorium L1:00, Anna Steckséns gata 53
Host: Michael Sundström, PhD, Scientific Director of European Initiatives SGC & Karolinska Institutet
Speaker: Anna Pasetto, Karolinska Institutet, Department of Laboratory Medicine (LABMED), Division of Clinical Microbiology
CMM Lecture Hall, L8:00, Visionsgatan 18
Host: Guro Gafvelin, Associate professor, Karolinska Institutet, Department of Clinical Neuroscience (CNS), CMM